Faucitis

Faucitis is the inflammation of the fauces, the anatomical region comprising the posterior oral cavity, including the palatoglossal and palatopharyngeal arches, the tonsillar pillars, and the tonsillar crypts. This condition is often considered a component of stomatitis or pharyngitis, but it specifically targets the oropharyngeal isthmus. Faucitis can be acute or chronic, localized or diffuse, and may be associated with systemic disease. It is characterized by erythema, edema, ulceration, and sometimes proliferative lesions of the faucial mucosa. The condition can cause significant discomfort, dysphagia, and salivation, and may lead to secondary complications such as aspiration pneumonia or anorexia. In veterinary medicine, faucitis is frequently observed in cats with chronic gingivostomatitis, but it can also occur in dogs and other species. The severity ranges from mild, self-limiting inflammation to severe, refractory disease requiring aggressive medical and surgical intervention.

The etiology of faucitis is multifactorial. Primary infectious agents include viral pathogens such as feline calicivirus (FCV), feline herpesvirus-1 (FHV-1), and feline immunodeficiency virus (FIV) in cats; canine distemper virus and canine papillomavirus in dogs. Bacterial infections, often secondary, involve anaerobic species (e.g., Fusobacterium, Porphyromonas) and aerobic pathogens (e.g., Pasteurella multocida, Streptococcus spp.). Fungal causes include Candida albicans (especially in immunocompromised patients) and, rarely, Cryptococcus neoformans. Parasitic causes are uncommon but may include Capillaria spp. in the oropharynx. Toxic etiologies include ingestion of caustic substances, certain plants (e.g., Dieffenbachia), or irritant chemicals. Autoimmune and immune-mediated mechanisms are implicated in chronic cases, particularly in feline chronic gingivostomatitis, where an exaggerated inflammatory response to dental plaque is observed. Genetic predisposition may play a role in certain breeds (e.g., Persian cats). Neoplastic causes, such as squamous cell carcinoma, can mimic faucitis. Environmental factors, including poor oral hygiene, dental disease, and stress, contribute to the development and perpetuation of inflammation.

Faucitis is most commonly reported in cats, with a higher prevalence in purebred cats, particularly Persians and Siamese. It can occur at any age but is more frequent in middle-aged to older animals. In dogs, faucitis is less common but may be seen in breeds with brachycephalic conformation due to anatomical crowding. There is no strong sex predilection. The condition is often associated with underlying viral infections, especially feline calicivirus, which is highly contagious and prevalent in multi-cat environments. Chronic faucitis is a significant component of feline chronic gingivostomatitis, affecting approximately 0.7% to 4% of cats in general practice. In dogs, faucitis may be secondary to dental disease, foreign bodies, or systemic infections. Geographic variation exists, with higher incidence in warmer climates where vector-borne diseases (e.g., leishmaniasis) may predispose to oral inflammation. Seasonality may influence viral shedding and transmission. Overall, the exact incidence is not well-documented, but it represents a common clinical presentation in small animal practice.

The pathophysiology of faucitis involves a complex interplay of microbial invasion, immune response, and tissue damage. Initially, mucosal injury (e.g., from viral infection, trauma, or irritants) disrupts the epithelial barrier, allowing bacterial colonization and invasion. Viral pathogens like FCV directly infect epithelial cells, causing cytolysis and ulceration. The host immune response, including innate and adaptive mechanisms, leads to vasodilation, increased vascular permeability, and recruitment of neutrophils, macrophages, and lymphocytes. Pro-inflammatory cytokines (e.g., TNF-α, IL-1, IL-6) are released, amplifying inflammation. In chronic cases, a dysregulated T-cell response, particularly Th1 and Th17, results in persistent lymphocytic infiltration and tissue remodeling. The tonsils, which are part of the fauces, may become hyperplastic or abscessed. Secondary bacterial infection exacerbates tissue necrosis and abscess formation. In severe cases, edema and proliferative lesions can obstruct the oropharyngeal passage, leading to dysphagia and respiratory compromise. Systemic effects include fever, anorexia, and dehydration. Chronic inflammation may predispose to neoplastic transformation, although this is rare.

Predisposing factors for faucitis include intrinsic and extrinsic elements. Intrinsic factors: (1) Genetic predisposition: certain breeds (e.g., Persian cats) have a higher risk of chronic gingivostomatitis and faucitis. (2) Age: older animals may have decreased immune function. (3) Immunosuppression: FIV, FeLV, or chronic corticosteroid use can increase susceptibility. (4) Anatomical abnormalities: brachycephalic breeds have crowded oral cavities, leading to poor ventilation and hygiene. (5) Metabolic diseases: diabetes mellitus, chronic kidney disease, and hyperthyroidism can impair mucosal immunity. Extrinsic factors: (1) Poor oral hygiene and dental disease (periodontitis, tooth resorption) provide a nidus for bacterial growth. (2) Diet: soft food may promote plaque accumulation. (3) Environmental stress: overcrowding, poor ventilation, and stress in multi-cat households increase viral transmission. (4) Concurrent infections: respiratory viruses, such as FCV and FHV-1, are major triggers. (5) Exposure to irritants: ingestion of caustic substances or certain plants. (6) Iatrogenic: oral surgery or intubation can cause trauma.

Clinical signs of faucitis vary with severity and chronicity. Peracute cases may present with sudden onset of hypersalivation, pawing at the mouth, and reluctance to eat. Acute faucitis is characterized by oral pain, dysphagia, and halitosis. On physical examination, the fauces appear erythematous, edematous, and may have ulcers or vesicles. The tonsils may be enlarged, hyperemic, or covered with exudate. Chronic faucitis often presents with proliferative, cauliflower-like lesions, especially in cats with chronic gingivostomatitis. Systemic signs include fever, lethargy, and anorexia. In severe cases, weight loss and dehydration are evident. Cats may exhibit a characteristic 'open-mouth breathing' due to pain. Dogs may show similar signs, along with excessive drooling and difficulty chewing. If the condition extends to the pharynx, coughing, gagging, and respiratory distress may occur. In terminal stages, severe ulceration and necrosis can lead to oronasal fistulas or aspiration pneumonia.

Differential diagnoses for faucitis include: (1) Stomatitis: diffuse inflammation of the oral mucosa, often involving the fauces, but more widespread. (2) Pharyngitis: inflammation of the pharynx, which may cause similar signs but is located more caudally. (3) Tonsillitis: primary inflammation of the tonsils, which can be a component of faucitis. (4) Oral neoplasia: squamous cell carcinoma, lymphoma, or melanoma can present as mass lesions or ulcers. (5) Eosinophilic granuloma complex (in cats): characterized by eosinophilic infiltrates, often affecting the lips and oral cavity. (6) Foreign body: a lodged foreign object (e.g., grass awn, bone) can cause localized inflammation. (7) Autoimmune diseases: pemphigus vulgaris or bullous pemphigoid can cause oral ulceration. (8) Metabolic diseases: chronic kidney disease can cause uremic stomatitis. (9) Toxic exposure: ingestion of caustic agents. (10) Fungal infections: candidiasis or cryptococcosis. Definitive diagnosis requires thorough oral examination, biopsy, and diagnostic imaging.

The diagnostic algorithm for faucitis begins with a thorough history and physical examination, including a complete oral examination under sedation or anesthesia. Step 1: Assess clinical signs and oral lesions; note the distribution and severity. Step 2: Perform baseline laboratory tests: complete blood count (CBC), serum biochemistry, and urinalysis to identify systemic disease. Step 3: Obtain oral swabs for viral PCR (e.g., FCV, FHV-1) and bacterial culture if infection is suspected. Step 4: Perform dental radiographs to evaluate for underlying dental disease (e.g., tooth resorption, periodontitis). Step 5: If lesions are proliferative or non-healing, perform a biopsy for histopathology and immunohistochemistry. Step 6: Consider advanced imaging (CT or MRI) if neoplasia or deep extension is suspected. Step 7: Rule out systemic diseases such as FIV/FeLV (in cats) and autoimmune disorders. Step 8: Based on findings, classify the faucitis as primary or secondary and initiate appropriate treatment. Confirmatory criteria include histopathological evidence of inflammation and identification of infectious agents.

Laboratory findings in faucitis are often non-specific but may reflect underlying causes. Hematology: CBC may show leukocytosis with a left shift due to bacterial infection, or lymphopenia due to viral infection. In chronic cases, mild anemia may be present. Serum biochemistry: Changes are usually related to dehydration (elevated BUN, creatinine, and total protein) or anorexia (mild elevations in liver enzymes). Electrolyte imbalances may occur if vomiting or diarrhea is present. Urinalysis: Typically unremarkable unless systemic disease is present. Blood gas analysis: May reveal metabolic acidosis if the animal is dehydrated or in shock. Specific biomarkers: Inflammatory markers such as C-reactive protein (CRP) may be elevated. Serology/PCR: In cats, testing for FIV and FeLV is recommended; PCR for FCV and FHV-1 can be performed on oral swabs. In dogs, serology for distemper or papillomavirus may be considered. Endocrine assays: If hyperthyroidism or diabetes is suspected, thyroid hormone levels and glucose/insulin assays are indicated. Overall, laboratory findings help identify concurrent diseases and guide therapy.

Imaging plays a limited but important role in the diagnosis of faucitis. Radiography: Dental radiographs are essential to evaluate for tooth root abscesses, periodontitis, or tooth resorption, which can contribute to faucitis. Thoracic radiographs may be indicated if aspiration pneumonia is suspected. Ultrasonography: Not typically used for faucitis, but may be helpful to assess cervical lymph nodes for metastasis or infection. Computed Tomography (CT): CT provides detailed images of the oral cavity and can identify deep tissue involvement, abscesses, or neoplasia. It is particularly useful for surgical planning. Magnetic Resonance Imaging (MRI): MRI offers superior soft tissue contrast and is valuable for evaluating the extent of inflammation or masses in the oropharyngeal region. Endoscopy: Oral endoscopy allows direct visualization of the fauces and can facilitate biopsy. Fluoroscopy: May be used to evaluate swallowing function if dysphagia is severe. Echocardiography: Not directly relevant, but may be performed if cardiac disease is suspected as a comorbidity.

Cytology: Fine needle aspirates (FNA) of enlarged tonsils or proliferative lesions can be performed. Smears may show inflammatory cells (neutrophils, lymphocytes, plasma cells) and, in some cases, infectious agents (bacteria, fungi). Cytology is useful for ruling out neoplasia but is not definitive. Histopathology: Biopsy is the gold standard for diagnosis. Histological features include epithelial ulceration, necrosis, and infiltration by inflammatory cells. In acute faucitis, neutrophils predominate; in chronic cases, lymphocytes and plasma cells are more common. Eosinophilic infiltrates may be seen in eosinophilic granuloma complex. Special stains (e.g., Gram stain, PAS) can identify bacteria or fungi. Immunohistochemistry may be used to detect viral antigens (e.g., FCV) or to characterize lymphocyte populations. Histopathology is essential to differentiate faucitis from neoplasia and to guide treatment.

Treatment of faucitis is multimodal and depends on the underlying cause and severity. Emergency stabilization: If the animal is dehydrated or anorexic, fluid therapy with balanced crystalloids (e.g., Lactated Ringer's solution) is initiated. Nutritional support via feeding tube (e.g., nasoesophageal, esophagostomy) may be necessary. Primary medical therapy: (1) Antimicrobials: For bacterial infections, amoxicillin-clavulanate (12.5-25 mg/kg PO q12h) or clindamycin (10-20 mg/kg PO q12h) are commonly used. Metronidazole (10-15 mg/kg PO q12h) may be added for anaerobic coverage. (2) Antivirals: In cats with FCV or FHV-1, famciclovir (40-90 mg/kg PO q8h) or interferon-omega (2.5 MU/kg SC q24h) may be used, though efficacy is variable. (3) Antifungals: For candidiasis, fluconazole (5-10 mg/kg PO q24h) or nystatin (100,000 IU PO q8h) is indicated. (4) Anti-inflammatory/immunosuppressive: Corticosteroids (e.g., prednisolone 1-2 mg/kg PO q24h) are used to reduce inflammation, but long-term use has side effects. Cyclosporine (5-10 mg/kg PO q24h) may be used in refractory cases. (5) Analgesics: NSAIDs (e.g., meloxicam 0.1 mg/kg PO q24h) or opioids (e.g., buprenorphine 0.01-0.02 mg/kg IV/SC q8-12h) are used for pain management. Surgical/interventional: In severe chronic faucitis, especially in cats, full-mouth or partial-mouth tooth extraction is often the most effective treatment. Laser ablation or cryotherapy may be used for proliferative lesions. Supportive care: Oral hygiene (chlorhexidine rinses), soft food, and environmental enrichment. Dietary modifications: High-quality, palatable, soft food to encourage eating. Physical rehabilitation: Not typically required, but gentle massage may help if the animal is reluctant to eat.

The prognosis for faucitis varies. Acute, uncomplicated cases often resolve with appropriate therapy within 1-2 weeks. Chronic cases, particularly feline chronic gingivostomatitis, have a guarded prognosis; many cats require long-term medical management or tooth extraction. The response to treatment is a key prognostic indicator: if clinical signs improve within 2-4 weeks of medical therapy, the prognosis is better. Negative prognostic factors include: severe proliferative lesions, concurrent FIV/FeLV infection, lack of response to medical therapy, and development of complications such as aspiration pneumonia. Mortality is low but can occur in severe cases due to anorexia and secondary infections. Long-term, many cats achieve good quality of life after tooth extraction, with resolution of clinical signs in up to 60-80% of cases. Recurrence is possible if underlying causes are not addressed.

Follow-up care is essential for monitoring response and preventing recurrence. Re-check intervals: Initially, re-examine every 1-2 weeks until clinical signs resolve. For chronic cases, re-evaluate every 3-6 months. Serial lab monitoring: CBC and biochemistry should be repeated if the animal is on long-term corticosteroids or cyclosporine. Drug levels may be monitored for cyclosporine. Repeat imaging: Dental radiographs should be taken after tooth extraction to ensure complete removal. If neoplasia is suspected, thoracic radiographs may be repeated every 3-6 months. Dose-titration: Corticosteroids should be tapered gradually to the lowest effective dose. Long-term management: Maintain good oral hygiene, provide a balanced diet, and minimize stress. In cats with chronic gingivostomatitis, consider early tooth extraction to improve outcomes. Owner education is crucial to ensure compliance.

Pearls: (1) Always perform a thorough oral examination under anesthesia to fully assess the fauces. (2) In cats with faucitis, test for FIV/FeLV and viral PCR. (3) Dental radiographs are essential to identify tooth root disease. (4) Early tooth extraction in cats with chronic gingivostomatitis can be curative. (5) Use a multimodal approach: antibiotics, anti-inflammatories, and analgesics. (6) Consider feeding tube placement if anorexia persists. Pitfalls: (1) Do not use NSAIDs in dehydrated or hypotensive animals. (2) Avoid long-term corticosteroids without addressing underlying dental disease. (3) Do not overlook systemic diseases that may cause faucitis. (4) Do not assume all faucitis is infectious; biopsy is needed for non-healing lesions. (5) Avoid using fluoroquinolones in young animals due to cartilage damage. (6) Do not neglect pain management, as oral pain can lead to anorexia and weight loss.

Based on Plumb's Veterinary Drug Handbook, the following protocols are recommended: (1) Amoxicillin-clavulanate: 12.5-25 mg/kg PO q12h for 7-14 days. (2) Clindamycin: 10-20 mg/kg PO q12h for 7-14 days. (3) Metronidazole: 10-15 mg/kg PO q12h for 5-7 days. (4) Famciclovir (cats): 40-90 mg/kg PO q8h for 7-21 days. (5) Interferon-omega (cats): 2.5 MU/kg SC q24h for 5 consecutive days, repeated as needed. (6) Fluconazole: 5-10 mg/kg PO q24h for 14-28 days. (7) Prednisolone: 1-2 mg/kg PO q24h, then taper over 2-4 weeks. (8) Cyclosporine: 5-10 mg/kg PO q24h, adjust based on trough levels (target 300-500 ng/mL). (9) Meloxicam: 0.1 mg/kg PO q24h for up to 3-5 days in cats; 0.2 mg/kg PO q24h in dogs. (10) Buprenorphine: 0.01-0.02 mg/kg IV/SC q8-12h. (11) Chlorhexidine oral rinse: 0.12% solution, apply to affected areas q12h. Adjust dosages for renal or hepatic impairment: reduce doses of renally excreted drugs (e.g., amoxicillin) in renal failure. Contraindications: NSAIDs in renal disease, corticosteroids in systemic infections. Drug interactions: Corticosteroids may increase risk of GI ulceration with NSAIDs; cyclosporine interacts with ketoconazole.

Key studies and consensus guidelines: (1) The American Veterinary Dental College (AVDC) guidelines recommend tooth extraction as the treatment of choice for feline chronic gingivostomatitis (FCGS), with a success rate of 60-80%. (2) A study by Hennet et al. (2011) found that full-mouth extraction was more effective than partial-mouth extraction in resolving clinical signs. (3) A randomized controlled trial by Lommer et al. (2013) showed that cyclosporine was effective in reducing inflammation in cats with FCGS, but tooth extraction remained superior. (4) The ISCAID (International Society for Companion Animal Infectious Diseases) guidelines for antimicrobial use in canine and feline oral infections recommend amoxicillin-clavulanate as first-line therapy. (5) A study by Veir et al. (2006) demonstrated that famciclovir reduced clinical signs in cats with FHV-1. (6) A meta-analysis by Winer et al. (2017) concluded that corticosteroids are effective for short-term relief but have significant side effects. (7) The ACVIM consensus statement on feline chronic gingivostomatitis (2020) emphasizes the importance of early tooth extraction and multimodal pain management. (8) Research by Southerden et al. (2018) highlighted the role of FCV in the pathogenesis of faucitis. (9) A study by Reiter et al. (2015) evaluated the use of CO2 laser for treatment of proliferative faucitis, showing promising results. (10) Long-term follow-up studies indicate that cats with FCGS have improved quality of life after tooth extraction, with reduced need for medication.